Evidence map›Paper›PMID 35023348›Full record

ArticleJournal of the American Heart Association2022

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)-Free Low-Density Lipoprotein Cholesterol.

Weili Zheng, Michael Chilazi, Jihwan Park, Vasanth Sathiyakumar, Leslie J Donato, Jeffrey W Meeusen, Mariana Lazo, Eliseo Guallar, Krishnaji R Kulkarni, Allan S Jaffe and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01698489 (The Very Large Database of Lipids), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01698489 active not recruitingnot on this map

The Very Large Database of Lipids (VLDL): A Clinical Laboratory Big Data Project

TypeobservationalSponsorJohns Hopkins UniversityRan2006 to 2030Enrolled5,051,467ConditionsLipid Disorders and Lipid Measurement
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?The Journal of clinical endocrinology and metabolism · 2024
    Article
  6. Review
  7. Extreme lipoprotein(a) in clinical practice: A cross sectional study.International journal of cardiology. Cardiovascular risk and prevention · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Weili ZhengDepartment of Cardiology Heart Vascular and Thoracic InstituteCleveland Clinic Cleveland OH.ORCID 0000-0002-7978-0569
Michael ChilaziCiccarone Center for the Prevention of Cardiovascular Disease Division of Cardiology Department of Medicine Johns Hopkins University School of Medicine Baltimore MD.ORCID 0000-0002-8942-2407
Jihwan ParkDepartment of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD.
Vasanth SathiyakumarCiccarone Center for the Prevention of Cardiovascular Disease Division of Cardiology Department of Medicine Johns Hopkins University School of Medicine Baltimore MD.
Leslie J DonatoDepartment of Laboratory Medicine and Pathology Mayo Clinic Rochester MN.ORCID 0000-0003-0126-7623
Jeffrey W MeeusenDepartment of Laboratory Medicine and Pathology Mayo Clinic Rochester MN.ORCID 0000-0002-0784-034X
Mariana LazoDepartment of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD.
Eliseo GuallarDepartment of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD.ORCID 0000-0002-4471-9565
Krishnaji R KulkarniVAP Diagnostics Laboratory Birmingham AL.
Allan S JaffeDepartment of Laboratory Medicine and Pathology Mayo Clinic Rochester MN.ORCID 0000-0003-1183-3959
Raul D SantosLipid Clinic Heart Institute (InCor)University of Sao Paulo Medical School Hospital Sao Paulo SP Brazil.ORCID 0000-0002-9860-6582
Peter P TothCiccarone Center for the Prevention of Cardiovascular Disease Division of Cardiology Department of Medicine Johns Hopkins University School of Medicine Baltimore MD.ORCID 0000-0001-5810-5460
Steven R JonesCiccarone Center for the Prevention of Cardiovascular Disease Division of Cardiology Department of Medicine Johns Hopkins University School of Medicine Baltimore MD.
Seth S MartinCiccarone Center for the Prevention of Cardiovascular Disease Division of Cardiology Department of Medicine Johns Hopkins University School of Medicine Baltimore MD.ORCID 0000-0002-7021-7622
Johns Hopkins University · USMayo Clinic in Arizona · USBirmingham VA Medical Center · USCleveland Clinic · USUniversidade de São Paulo · BR

Funding

Sex Hormones in Pulmonary Arterial HypertensionP01HL108800 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEMNES, ANNA R · 2012 to 2021
$22.0M
NHLBI NIH HHS P01 HL108800
6 · The paper itself

Abstract

Background Accurate measurement of the cholesterol within lipoprotein(a) (Lp[a]-C) and its contribution to low-density lipoprotein cholesterol (LDL-C) has important implications for risk assessment, diagnosis, and treatment of atherosclerotic cardiovascular disease, as well as in familial hypercholesterolemia. A method for estimating Lp(a)-C from particle number using fixed conversion factors has been proposed (Lp[a]-C from particle number divided by 2.4 for Lp(a) mass, multiplied by 30% for Lp[a]-C). The accuracy of this method, which theoretically can isolate "Lp(a)-free LDL-C," has not been validated. Methods and Results In 177 875 patients from the VLDbL (Very Large Database of Lipids), we compared estimated Lp(a)-C and Lp(a)-free LDL-C with measured values and quantified absolute and percent error. We compared findings with an analogous data set from the Mayo Clinic Laboratory. Error in estimated Lp(a)-C and Lp(a)-free LDL-C increased with higher Lp(a)-C values. Median error for estimated Lp(a)-C <10 mg/dL was -1.9 mg/dL (interquartile range, -4.0 to 0.2); this error increased linearly, overestimating by +30.8 mg/dL (interquartile range, 26.1-36.5) for estimated Lp(a)-C ≥50 mg/dL. This error relationship persisted after stratification by overall high-density lipoprotein cholesterol and high-density lipoprotein cholesterol subtypes. Similar findings were observed in the Mayo cohort. Absolute error for Lp(a)-free LDL-C was +2.4 (interquartile range, -0.6 to 5.3) for Lp(a)-C<10 mg/dL and -31.8 (interquartile range, -37.8 to -26.5) mg/dL for Lp(a)-C≥50 mg/dL. Conclusions Lp(a)-C estimations using fixed conversion factors overestimated Lp(a)-C and subsequently underestimated Lp(a)-free LDL-C, especially at clinically relevant Lp(a) values. Application of inaccurate Lp(a)-C estimations to correct LDL-C may lead to undertreatment of high-risk patients.

Indexed as

Hyperlipoproteinemia Type IILipoprotein(a)CholesterolCholesterol, HDLCholesterol, LDLHumansCholesterolCholesterol, HDLCholesterol, LDLLipoprotein(a)LDL‐Clipoprotein(a)

Identifiers

PMID35023348
PMCPMC9238537
OpenAlexW4205699007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.